ND

Nandita Das Majumdar

Active Director Director DIN 11062230
DIN 11062230 First appointment Apr 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Nandita Das Majumdar

Data last updated:

Nandita Das Majumdar is a Director at Asteroxylone Nutrition Private Limited (since 2025). Asteroxylone Nutrition Private Limited reported revenue of ₹29.2 Lakh (FY 2026).

DIN 11062230
Primary Designation Director
First Appointment 18 Apr 2025
Oldest Company Age 1 yrs
Largest company Asteroxylone Nutrition Private Limited · ₹29.2 Lakh (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Apr 20252025₹29.2 Lakh (FY 2026)Active

Board colleagues of Nandita Das Majumdar

NameDINCompanyDesignation
Priyanka Dev11062231Asteroxylone Nutrition Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asteroxylone Nutrition Private Limited
Premium access

Shareholding and investment profile for Nandita Das Majumdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandita Das Majumdar

Nandita Das Majumdar currently holds 1 directorship: Asteroxylone Nutrition Private Limited (Director, since 18 Apr 2025, revenue ₹29.2 Lakh (FY 2026)).

Nandita Das Majumdar was first appointed on 18 Apr 2025 as Director at Asteroxylone Nutrition Private Limited.

The current boards of Nandita Das Majumdar's companies include Priyanka Dev (Asteroxylone Nutrition Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available